Elon Musk’s Neuralink has known about problems with its brain chip implant for years, report saysByBruce GilPublishedMay 15, 2024
Pete Buttigieg is 'speechless' that airlines are suing to block rules against hidden feesByBruce GilUpdatedMay 15, 2024
A pill could solve the Zepbound and Wegovy shortage, Eli Lilly executive saysByBruce GilUpdatedMay 15, 2024
People taking the weight loss drug Wegovy are keeping the weight off for years, study saysByBruce GilPublishedMay 14, 2024
The owner of De Beers is spinning off the diamond brand as it fights a takeoverByBruce GilUpdatedMay 14, 2024
Johnson & Johnson is selling off its stake in the maker of Tylenol and Band-AidsByBruce GilPublishedMay 13, 2024
Merck stopped a clinical trial for its experimental skin cancer drug after a high rate of side effectsByBruce GilPublishedMay 13, 2024
Microsoft, Amazon, Pfizer, and others are investing a record $16 billion in FranceByBruce GilPublishedMay 13, 2024
The FTC is challenging 'junk' drug patents. Here's what they are and why they matterByBruce GilUpdatedMay 8, 2024
Amazon is about to start advertising Amazon products when Prime Video users hit pauseByBruce GilPublishedMay 8, 2024
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's howByBruce GilUpdatedMay 8, 2024
Steward Health Care is seeking a bailout in one of the largest hospital bankruptcies in decadesByBruce GilPublishedMay 6, 2024
Amgen teased trial results for its potential Ozempic competitor — and the stock surged 13%ByBruce GilPublishedMay 3, 2024
Wegovy sales surge, COVID vax sales sink, and 'junk' patents: Pharma news roundupByBruce GilPublishedMay 3, 2024
Sony and Apollo want to buy Paramount for $26 billion in cash — and the stock soars 13%ByBruce GilUpdatedMay 2, 2024
